Written by
Bilal H
Bilal H Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Getting a diagnosis of cancer in the lymph nodes of the neck can be scary. It makes you wonder about survival, treatment, and what’s next. At Liv Hospital, we focus on advanced, patient-centered care. Knowing the latest about this condition helps you make better health choices.

The 5-year survival rate for neck lymph node cancer is about 62“73%. But, it falls to 19“33% if the cancer has spread. We’ll share important facts about neck lymph node cancer. This will help you feel more confident about your care.

Key Takeaways

  • Understanding the 5-year survival rate for cancer in lymph nodes in the neck is key for patients.
  • The survival rate changes a lot based on how far the disease has spread.
  • Early diagnosis and treatment are critical to better survival chances.
  • People with cancer that’s only in the lymph nodes have a better chance of survival than those with cancer that has spread.
  • Liv Hospital is committed to giving full care to patients with neck lymph node cancer.

What Is Cervical Lymph Node Cancer?

image 748 LIV Hospital
Cancer in Lymph Nodes in Neck Survival Rate: 7 Key Facts You Should Know 2

Lymph nodes are small, bean-shaped structures in our body. They are part of the lymphatic system, which fights infection and disease. When cancer develops in these nodes, it’s called cervical lymph node cancer.

Lymph nodes filter out pathogens and abnormal cells, including cancer cells. They are key to our immune system, protecting us from disease. In the neck, they help guard the head and neck from infection.

The Role of Lymph Nodes in Your Body

Lymph nodes are found all over the body, but more in the neck, armpits, and groin. They contain immune cells called lymphocytes that fight infection. When the body detects an infection, lymph nodes swell as they work to fight it off.

Primary vs. Secondary Lymph Node Cancer

Cervical lymph node cancer can be primary or secondary. Primary cancer, or lymphoma, starts in the lymph nodes. Secondary cancer happens when cancer from another part of the body spreads to the neck lymph nodes.

Primary lymphomas include Hodgkin and non-Hodgkin lymphoma, each needing different treatments. Secondary cancer is a sign of advanced disease, needing a treatment plan that addresses both the original cancer and the lymph nodes.

The outlook for cervical lymph node cancer depends on whether it’s primary or secondary. It also depends on the cancer’s stage and the patient’s overall health. Knowing these factors helps in creating an effective treatment plan and improving survival chances.

Key Fact #1: Recognizing the Warning Signs

It’s important to know the warning signs of neck lymph node cancer early. This can lead to better treatment and survival rates. We’ll look at common symptoms and how to tell if swelling is cancerous.

Common Symptoms of Neck Lymph Node Cancer

Neck lymph node cancer often shows clear symptoms. These can make people seek medical help. Common signs include:

  • A persistent lump or swelling in the neck
  • Pain or discomfort in the neck area
  • Difficulty swallowing or breathing
  • Systemic symptoms such as fever, night sweats, or unexplained weight loss

These symptoms are serious and shouldn’t be ignored. If you notice any, see a doctor right away.

Differentiating Cancerous from Non-Cancerous Swelling

Not all neck swelling is cancer. Infections and inflammatory diseases can also cause it. But, some signs might point to cancer:

  1. Persistence: Swelling that doesn’t go away or with antibiotics.
  2. Size and Growth: Lymph nodes that are big or getting bigger.
  3. Hardness and Fixation: Lymph nodes that are hard, stuck to nearby tissues, or not soft to touch.

Doctors use physical exams, imaging studies, and biopsies to find out what’s causing swelling. Knowing this can help people understand their treatment better.

Spotting the warning signs early can lead to better treatment and survival chances. Knowing the symptoms and how to tell if swelling is cancerous helps people take care of their health.

Improving survival rates in neck lymph node cancer means early detection and good treatment plans. This includes using advanced surgery, radiation, and treatments like chemotherapy and targeted therapy.

Key Fact #2: Cancer in Lymph Nodes in Neck Survival Rate Statistics

When you’re diagnosed with cancer in your neck’s lymph nodes, knowing the survival stats is key. It helps you understand your chances and guides your treatment choices.

Survival Rates for Localized Disease

Cancer in the neck’s lymph nodes that hasn’t spread is more hopeful. The 5-year survival rate for this is 62% to 73%. This means many patients can live long with the right treatment.

Impact of Distant Metastasis on Survival

But, if cancer has spread to other parts of your body, the outlook is tougher. The 5-year survival rate drops to 19% to 33%. This shows how vital early detection and treatment are.

Stage5-Year Survival Rate
Localized62-73%
Distant Metastasis19-33%

It’s vital for patients and their families to grasp these survival stats. While they give a general view, your actual outcome depends on many things. These include your health, how well you respond to treatment, and the cancer’s specifics.

Key Fact #3: Critical Factors That Determine Prognosis

When it comes to neck lymph node cancer, knowing the prognosis is key. It involves looking at several important factors. These factors help doctors decide on the best treatment and predict how well a patient will do.

Pathological Type and Grade of Cancer

The type and grade of cancer are very important. Different cancers grow and spread at different rates. This affects how well they can be treated.

For example, some lymphomas are easier to treat than others. The grade of the cancer also matters. Higher grades grow and spread faster, leading to a worse outlook.

Number and Location of Affected Lymph Nodes

The number and location of lymph nodes affected by cancer are also key. More nodes mean a worse prognosis. Where these nodes are located also matters.

Cancer in lower neck nodes might have a different outlook than upper neck nodes. Knowing how many nodes are affected helps doctors stage the disease right. This is important for planning treatment.

Impact of Extranodal Extension

Extranodal extension (ENE) is when cancer spreads beyond the lymph node. This is a big deal because it means the cancer is more aggressive. Studies show ENE can affect how well the cancer can be controlled and survival rates.

For more on how cancer staging affects prognosis, check out this resource on cancer staging.

Prognostic FactorDescriptionImpact on Prognosis
Pathological Type and GradeType and aggressiveness of cancer cellsHigher grade = poorer prognosis
Number and Location of Affected Lymph NodesExtent and location of lymph node involvementMore nodes or critical locations = poorer prognosis
Extranodal Extension (ENE)Spread of cancer beyond lymph node capsulePresence of ENE = poorer prognosis

Understanding these factors helps doctors predict outcomes better. They can then tailor treatments to improve survival and quality of life for neck lymph node cancer patients.

Key Fact #4: Understanding the Staging Process

Knowing the stage of neck lymph node cancer is key for the right treatment. The staging process shows how far the disease has spread. This is important for planning treatment and guessing how well it will work.

The TNM Classification System Explained

The TNM system is a common way to stage cancer, like neck lymph node cancer. It looks at three main things: the size and spread of the Tumor (T), how much nearby Lymph Nodes (N) are affected, and if the cancer has spread to other parts of the body (M).

Doctors use this system to accurately stage cancer and decide on treatments. The TNM system helps everyone involved in care talk the same language. It also helps find the best treatment plans.

How Advanced Nodal Status Affects Prognosis

The extent of lymph node involvement, or nodal status, is very important for predicting how well a patient will do. If the cancer has spread to more lymph nodes, it’s harder to treat. This can lower the chances of survival.

To show how nodal status affects survival, here’s a table with 5-year survival rates based on lymph node involvement:

Nodal StatusDescription5-Year Survival Rate
N0No regional lymph nodes involved62-73%
N1-N3Regional lymph nodes involved19-33%

The table shows that survival rates drop with more advanced nodal status. Knowing the nodal status helps doctors predict outcomes. They can then create treatment plans that are more likely to work.

Key Fact #5: Modern Treatment Approaches

Medical technology has made big strides in treating neck lymph node cancer. Now, we use a mix of treatments to help patients. This approach aims to get the best results.

Surgical Options for Neck Lymph Node Cancer

Surgery is key in fighting neck lymph node cancer. Neck dissection is a common surgery. It removes the bad lymph nodes and sometimes more.

The goal is to get rid of the cancer and stop it from spreading.

  • Selective neck dissection: Removes specific lymph node groups.
  • Modified radical neck dissection: Preserves certain non-lymphatic structures.
  • Radical neck dissection: Involves the removal of lymph nodes and additional structures.

The right surgery depends on the cancer’s size and where it is. It also depends on the patient’s health.

Radiation Therapy Protocols

Radiation therapy is a big part of treating neck lymph node cancer. It uses rays to kill or slow cancer cells. Intensity-modulated radiation therapy (IMRT) helps target the tumor without harming nearby healthy tissues.

Radiation therapy can be used:

  1. As a primary treatment for early-stage cancer.
  2. In combination with surgery for more advanced cases.
  3. To alleviate symptoms in palliative care.

Systemic Treatments: Chemotherapy and Targeted Therapy

Chemotherapy and targeted therapy are key in managing neck lymph node cancer. They are most important when the cancer has spread.

Chemotherapy uses drugs to kill cancer cells all over the body. It’s often used with surgery or radiation therapy.

Targeted therapy attacks specific molecules that help cancer grow. This helps stop the cancer’s spread while protecting healthy cells.

These modern treatments, used alone or together, have greatly improved neck lymph node cancer care. Knowing these options helps patients make better choices for their treatment.

Key Fact #6: Recent Advancements Improving Survival

The treatment for neck lymph node cancer is getting better. New methods are helping patients live longer. These changes have made a big difference in survival rates.

Benefits of Induction Chemotherapy

Induction chemotherapy is a new way to treat cancer. It’s given before the main treatment. This method helps shrink tumors, making them easier to treat later.

By making tumors smaller, induction chemotherapy can make other treatments work better. This leads to better results for patients.

Precision Radiotherapy Techniques

New radiotherapy methods are also helping. Precision radiotherapy, like IMRT, targets tumors more accurately. This means less harm to healthy tissues.

This precision lowers the chance of side effects. It also makes life better for those getting treated for neck lymph node cancer.

Immunotherapy and Biological Treatments

Immunotherapy is a new hope for fighting cancer. Biological treatments aim at specific cancer cells. They offer new hope for advanced neck lymph node cancer patients.

These treatments are being tested in trials. They show promise in boosting survival rates and cutting down on cancer coming back.

As we learn more about treating neck lymph node cancer, patients will get better care. This could lead to longer lives and a better quality of life.

Key Fact #7: Possibility of Long-Term Remission

Understanding what helps with long-term remission is key to better patient outcomes. Long-term remission is a big goal for those with neck lymph node cancer. We’ll look at what affects this outcome and why managing recurrence risk is vital for lasting health.

Factors Associated with Better Long-Term Outcomes

Several factors lead to better long-term results for neck lymph node cancer patients. These include early diagnosis, effective treatments, and thorough follow-up care. Early detection leads to quicker action, which boosts survival chances.

Choosing the right treatment is also essential. This might be surgery, radiation, chemotherapy, or a mix. The treatment depends on the cancer’s stage, type, and the patient’s health.

FactorDescriptionImpact on Outcome
Early DiagnosisTimely detection of cancerImproves survival rates
Effective TreatmentAppropriate choice of therapyEnhances long-term remission
Follow-up CareRegular monitoring post-treatmentReduces recurrence risk

Monitoring and Managing Recurrence Risk

Keeping an eye on recurrence risk is vital for long-term care in neck lymph node cancer patients. Regular check-ups and watching for recurrence signs help catch problems early. This allows for quick action.

A detailed follow-up plan is essential. This might include regular visits, imaging, and other tests. Being proactive and vigilant helps patients and doctors work together. This way, they can lower recurrence risk and keep health stable over time.

Living Well After Diagnosis: Practical Guidance

Getting a diagnosis of neck lymph node cancer can change your life. But, there are steps you can take to feel better. Managing side effects, getting emotional support, and changing your lifestyle are key to a better life.

Managing Treatment Side Effects

Handling side effects well is important for your quality of life. Treatments like surgery, radiation, and chemotherapy can cause different problems.

  • Radiation Therapy: You might feel tired, have skin changes, or trouble swallowing. Taking care of your skin and eating well can help.
  • Chemotherapy: Side effects include nausea, hair loss, and infections. Medicines and care can help with these issues.

Emotional and Psychological Support Resources

Getting emotional and psychological support is key when you have neck lymph node cancer. The right help can make a big difference in how you cope.

“The emotional support I received during my treatment was invaluable. It helped me cope with the stress and anxiety of my diagnosis.” – Patient testimonial

Here are some support options:

  • Counseling services
  • Support groups
  • Online forums and resources

Lifestyle Modifications That May Help

Changing your lifestyle can also help your health. This includes eating better, moving more, and managing stress.

Lifestyle ModificationPotential Benefits
Dietary ChangesImproved nutrition, enhanced recovery
Increased Physical ActivityReduced fatigue, improved overall health
Stress ManagementReduced anxiety, improved mental well-being

By following these tips and making lifestyle changes, patients with neck lymph node cancer can live better. They might even live longer.

Conclusion: Navigating Your Cancer Journey

Understanding cancer in lymph nodes in the neck is key. It helps patients make smart choices about their treatment. Knowing the survival rates can guide them in their care.

Several factors affect how well a patient will do. These include the type and grade of cancer, how many lymph nodes are affected, and where they are. Patients can work with their doctors to create a treatment plan that fits them.

Today, treatments like surgery, radiation, and systemic treatments are helping more people survive. New methods like induction chemotherapy, precise radiotherapy, and immunotherapy are also showing great promise.

Patients can face their cancer journey with hope by staying informed and getting the right support. A focus on the patient is essential. It ensures they get the care and support needed for the best outcomes.

References

  1. SEER Cancer Statistics (National Cancer Institute): Cervix Uteri Cancer Statistics
  2. Nature: Article on the Role of the HPV E6 Oncoprotein in Cervical Cancer
  3. PubMed Central (NCBI): Predictive Markers and Prognosis in Cervical Cancer
  4. American Cancer Society (Cancer.org): Cervical Cancer Survival Rates
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91